These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


344 related items for PubMed ID: 19136530

  • 1. Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Leonard SN, Rossi KL, Newton KL, Rybak MJ.
    J Antimicrob Chemother; 2009 Mar; 63(3):489-92. PubMed ID: 19136530
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    Sader HS, Jones RN, Rossi KL, Rybak MJ.
    J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978
    [Abstract] [Full Text] [Related]

  • 3. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S.
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [Abstract] [Full Text] [Related]

  • 4. Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method.
    Satola SW, Farley MM, Anderson KF, Patel JB.
    J Clin Microbiol; 2011 Jan; 49(1):177-83. PubMed ID: 21048008
    [Abstract] [Full Text] [Related]

  • 5. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus.
    Fitzgibbon MM, Rossney AS, O'Connell B.
    J Clin Microbiol; 2007 Oct; 45(10):3263-9. PubMed ID: 17687008
    [Abstract] [Full Text] [Related]

  • 6. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M, Ermertcan S, Taşli H, Kurutepe S.
    Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
    [Abstract] [Full Text] [Related]

  • 7. Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.
    Richter SS, Satola SW, Crispell EK, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Diekema DJ, Doern GV.
    J Clin Microbiol; 2011 Dec; 49(12):4203-7. PubMed ID: 21976769
    [Abstract] [Full Text] [Related]

  • 8. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
    Bernard L, Vaudaux P, Rohner P, Huggler E, Armanet M, Pittet D, Lew DP, Schrenzel J.
    J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.
    Walsh TR, Bolmström A, Qwärnström A, Ho P, Wootton M, Howe RA, MacGowan AP, Diekema D.
    J Clin Microbiol; 2001 Jul; 39(7):2439-44. PubMed ID: 11427551
    [Abstract] [Full Text] [Related]

  • 10. Low-level glycopeptide resistance in methicillin-resistant Staphylococcus aureus and how to test it.
    Hawkey PM.
    Clin Microbiol Infect; 2009 Dec; 15 Suppl 7():2-9. PubMed ID: 19951328
    [Abstract] [Full Text] [Related]

  • 11. A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital.
    Garnier F, Chainier D, Walsh T, Karlsson A, Bolmström A, Grelaud C, Mounier M, Denis F, Ploy MC.
    J Antimicrob Chemother; 2006 Jan; 57(1):146-9. PubMed ID: 16286482
    [Abstract] [Full Text] [Related]

  • 12. [The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus].
    Feng NN, Wang Q, Song YL, He LX, Zhou CM, Xie HM, Li HY.
    Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):318-22. PubMed ID: 23925360
    [Abstract] [Full Text] [Related]

  • 13. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C, Denis O, Struelens MJ.
    Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.
    Yusof A, Engelhardt A, Karlsson A, Bylund L, Vidh P, Mills K, Wootton M, Walsh TR.
    J Clin Microbiol; 2008 Sep; 46(9):3042-7. PubMed ID: 18596146
    [Abstract] [Full Text] [Related]

  • 15. Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.
    Pitz AM, Yu F, Hermsen ED, Rupp ME, Fey PD, Olsen KM.
    J Clin Microbiol; 2011 Jan; 49(1):269-74. PubMed ID: 20962147
    [Abstract] [Full Text] [Related]

  • 16. Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia.
    Hegde SS, Skinner R, Lewis SR, Krause KM, Blais J, Benton BM.
    J Antimicrob Chemother; 2010 Apr; 65(4):725-8. PubMed ID: 20139142
    [Abstract] [Full Text] [Related]

  • 17. Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods.
    Riederer K, Shemes S, Chase P, Musta A, Mar A, Khatib R.
    J Clin Microbiol; 2011 Jun; 49(6):2147-50. PubMed ID: 21490190
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
    Sader HS, Becker HK, Moet GJ, Jones RN.
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):329-31. PubMed ID: 20159377
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneous vancomycin resistance in Staphylococcus aureus: a review of epidemiology, diagnosis, and clinical significance.
    Rong SL, Leonard SN.
    Ann Pharmacother; 2010 May; 44(5):844-50. PubMed ID: 20332341
    [Abstract] [Full Text] [Related]

  • 20. Detection of heterogeneous, intermediate-vancomycin-resistant Staphylococcus aureus (hVISA) using low-concentration vancomycin disks.
    Lulitanond A, Chanawong A, Sribenjalux P, Kaewkes W, Vorachit M, Chongtrakool P, Leumsai D, Monpou P.
    Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):761-7. PubMed ID: 17121303
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.